Ann: Creso & Halucenex welcome Californian Senate Bill, page-10

"The recent development highlights a major market opportunity for Creso Pharma and Halucenex, which it intends to capitalise on in the near term."

Nice operational update. Hopefully the lingering archaic historic/traditional views from the 60s and 70s that have hindered cannabis will not be the same for the new age medicinal psychedelics market.

"Creso Pharma will continue to bolster its exposure to the US market in an attempt to become afirst mover in the psychedelic sector. New hires to add support to expansion efforts are currentlybeing explored."

Aggressive business posturing is needed if CPH want to be a first mover. I'm expecting an increase in admin/opex costs coming up next quarter

"The Company is also pursuing DTC eligibility for its upcoming OTCQB (“OTC”) dual listing, which will allow for real time electronic trades of Creso Pharma’s securities and easier access for North American investors. This is expected near term and will provide additional exposure for Creso Pharma during a pivotal growth period."

This is juicy. Looks to be the last hurdle before we go live on the US OTC mid-tier market. This represents an important step forward in increasing liquidity, broadening our shareholder base and building a strong presence for CPH within the US capital markets.

DTC eligibility submission is no doubt filed and underway - could take anywhere between 2 business days and 4 weeks but the US listing is very imminent.